Related content

Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours

By                                

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 677-681

Spandidos Publications

Access to resources Recommend Favorite

Surgical debulking of gastrointestinal stromal tumors: Is it a reasonable option after second-line treatment with sunitinib?

By Pantaleo M.   Di Battista M.   Catena F.   Astorino M.   Saponara M.   Di Scioscio V.   Santini D.   Piazzi G.   Castellucci P.   Brandi G.   Biasco G.  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 625-630

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of sunitinib in Chinese patients with imatinib-resistant or -intolerant gastrointestinal stromal tumors

By Li Jian   Gao Jing   Hong Jinlin   Shen Lin  

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 617-624

Future Medicine

Access to resources Recommend Favorite

Molecular characterisation of gastrointestinal stromal tumours in a South African population

By                  

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 155-160

Spandidos Publications

Access to resources Recommend Favorite

Sunitinib as first-line neoadjuvant therapy in two patients with rectal stromal tumors

By Weidong Gan   Feng Qu   Xitai Sun   Xiang Yan   Hongqian Guo   Ruipeng Jia  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1697-1701

Future Medicine

Access to resources Recommend Favorite